Evaluation of Chronic and Acute Beetroot Juice Supplementation on Submaximal VO2 in High-Level Athletes
The goal of this randomized crossover clinical trial is to determine whether acute or subacute nitrate supplementation with concentrated beetroot juice improves submaximal exercise performance in elite athletes. The optimal nitrate supplementation regimen using concentrated beetroot juice has not yet been clearly established. The main questions it aims to answer are:
- Does subacute nitrate supplementation, consisting of seven days of twice-daily Beet It Sport consumption followed by an additional dose on the morning of testing, improve submaximal exercise performance compared with acute nitrate supplementation alone?
- Does subacute nitrate supplementation result in greater improvements in submaximal oxygen consumption (VO₂), time to exhaustion, and physiological responses during exercise than acute nitrate supplementation?
Researchers will compare the two nitrate supplementation regimens in the same athletes to determine which approach provides the greatest improvement in submaximal exercise performance. Participants will be randomly assigned to one of two groups, each completing both supplementation regimens in a different order, with a 2-4-week washout period between interventions to minimize potential carryover effects.
Participants will:
- Complete the recruitment and informed consent process.
- Attend three study visits, including an initial VO₂ max assessment and subsequent exercise testing visits.
- Complete both supplementation regimens in a randomized crossover design:
- Subacute nitrate supplementation: Consume 70 mL of Beet It Sport twice daily for seven days before the exercise test, followed by 140 mL on the morning of the test.
- Acute nitrate supplementation: Consume 70 mL of placebo twice daily for seven days before the exercise test, followed by 140 mL of Beet It Sport on the morning of the test.
- Undergo exercise testing, including submaximal VO₂ assessment and a time-to-exhaustion test, as well as measurements of vital signs and capillary blood lactate levels.
- Complete a questionnaire assessing adherence to the assigned supplementation regimen.
No additional follow-up will be required after the study visits. The findings may help establish the most effective nitrate supplementation regimen using concentrated beetroot juice to optimize submaximal exercise performance in elite athletes.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Quebec
-
Sherbrooke、Quebec、カナダ、J1G 2Y9
- Université de Sherbrooke
-
コンタクト:
- Benoit Genest
- 電話番号:4506014311
- メール:benoit.genest2@usherbrooke.ca
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adult male or female aged 30 years or younger
- Active member of the University of Sherbrooke Vert & Or cross-country or athletics team, or the Sherbrooke Athletics Club
Exclusion Criteria:
- Daily beetroot juice consumption
- Injury limiting participation in competitions or training
- Beetroot or lemon allergy
- Known cardiac, pulmonary, or metabolic disease except treated asthma
- Use of medications other than contraceptives or asthma inhalers
- Smoking or vaping
- Pregnancy
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の:Acute Administration First
Acute first |
Complete both supplementation regimens in a crossover design:
|
|
他の:Subacute First
Subacute first |
Complete both supplementation regimens in a randomized crossover design:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Submaximal exercise test
時間枠:1 hours
|
V02 max |
1 hours
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time to exhaustion test
時間枠:1 hour
|
Time in secondes |
1 hour
|
|
Capillary blood lactate concentrations during exercise testing
時間枠:1 hour
|
(mmol/L) |
1 hour
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2027-6544
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。